4-Phenyl-1,3-thiazole-2-amines as scaffolds for new antileishmanial agents

BACKGROUND: There is still a need for new alternatives in pharmacological therapy for neglected diseases, as the drugs available show high toxicity and parenteral administration. That is the case for the treatment of leishmaniasis, particularly to the cutaneous clinical form of the disease. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigues, Carina Agostinho, dos Santos, Paloma Freire, da Costa, Marcela Oliveira Legramanti, Pavani, Thais Fernanda Amorim, Xander, Patrícia, Geraldo, Mariana Marques, Mengarda, Ana, de Moraes, Josué, Rando, Daniela Gonçales Galasse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131760/
https://www.ncbi.nlm.nih.gov/pubmed/30214457
http://dx.doi.org/10.1186/s40409-018-0163-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131760/
https://www.ncbi.nlm.nih.gov/pubmed/30214457
http://dx.doi.org/10.1186/s40409-018-0163-x

Ejemplares similares